IL22 and urinary bladder carcinoma: When stratifying according to the stage of bladder cancer, we found that superficial bladder cancer had a significantly lower frequency of the IL-22 -429 TT genotype (OR=0.48, 95% CI=0.23, 0.98; p=0.04) (Table 4).